Istvan Molnar
Chair, Applied BioSciences - GIDP
Chair, Arid Lands Resources Sciences - GIDP
Professor, Natural Resources and the Environment
Professor, BIO5 Institute
Professor, Plant Sciences
Primary Department
Department Affiliations
(520) 621-9932
Research Interest
Dr. Istvan Molnar is a Professor at the School of Natural Resources and the Environment, and the associate director of the Natural Products Center. He is a microbial geneticist specializing on the characterization and engineering of secondary metabolite biosynthetic pathways of microorganisms. He tries to understand the genetic “software” that governs the production of natural products in microorganisms, and to exploit this understanding to re-write this software to produce life-saving drugs and valuable chemicals using the “wetware” of microbial cells. He is using methods of microbial systems biology, synthetic biology, genomics, combinatorial biosynthesis and a dash of natural product chemistry to optimize the production of known natural products, and to produce completely new ones, for the discovery and development of medically useful drugs. Dr. Molnar has worked in the biotech industry in different countries before joining the University of Arizona in 2004. He is the author of >50 publications and holds 10 international patents. His lab has been supported by the National Health Institute, National Institute of General Medical Sciences and US Department of Agriculture, National Institute of Food and Agriculture. Dr. Molnar is also the Chair of two Graduate Interdisciplinary Programs: the Arid Lands Resource Sciences GIDP and the Professional Science Masters in Applied Biosciences GIDP.

Publications

Xu, Y., Espinosa-Artiles, P., Schubert, V., Xu, Y., Zhang, W., Lin, M., Gunatilaka, A. A., Süssmuth, R., & Molnár, I. (2013). Characterization of the biosynthetic genes for 10,11-dehydrocurvularin, a heat shock response-modulating anticancer fungal polyketide from Aspergillus terreus. Applied and environmental microbiology, 79(6).
BIO5 Collaborators
Leslie Gunatilaka, Istvan Molnar

10,11-Dehydrocurvularin is a prevalent fungal phytotoxin with heat shock response and immune-modulatory activities. It features a dihydroxyphenylacetic acid lactone polyketide framework with structural similarities to resorcylic acid lactones like radicicol or zearalenone. A genomic locus was identified from the dehydrocurvularin producer strain Aspergillus terreus AH-02-30-F7 to reveal genes encoding a pair of iterative polyketide synthases (A. terreus CURS1 [AtCURS1] and AtCURS2) that are predicted to collaborate in the biosynthesis of 10,11-dehydrocurvularin. Additional genes in this locus encode putative proteins that may be involved in the export of the compound from the cell and in the transcriptional regulation of the cluster. 10,11-Dehydrocurvularin biosynthesis was reconstituted in Saccharomyces cerevisiae by heterologous expression of the polyketide synthases. Bioinformatic analysis of the highly reducing polyketide synthase AtCURS1 and the nonreducing polyketide synthase AtCURS2 highlights crucial biosynthetic programming differences compared to similar synthases involved in resorcylic acid lactone biosynthesis. These differences lead to the synthesis of a predicted tetraketide starter unit that forms part of the 12-membered lactone ring of dehydrocurvularin, as opposed to the penta- or hexaketide starters in the 14-membered rings of resorcylic acid lactones. Tetraketide N-acetylcysteamine thioester analogues of the starter unit were shown to support the biosynthesis of dehydrocurvularin and its analogues, with yeast expressing AtCURS2 alone. Differential programming of the product template domain of the nonreducing polyketide synthase AtCURS2 results in an aldol condensation with a different regiospecificity than that of resorcylic acid lactones, yielding the dihydroxyphenylacetic acid scaffold characterized by an S-type cyclization pattern atypical for fungal polyketides.

Yuquan, X. u., Orozco, R., Wijeratne, E. K., Gunatilaka, A. L., Stock, S. P., & Molnár, I. (2008). Biosynthesis of the Cyclooligomer Depsipeptide Beauvericin, a Virulence Factor of the Entomopathogenic Fungus Beauveria bassiana. Chemistry and Biology, 15(9), 898-907.
BIO5 Collaborators
Leslie Gunatilaka, Istvan Molnar

PMID: 18804027;Abstract:

Beauvericin, a cyclohexadepsipeptide ionophore from the entomopathogen Beauveria bassiana, shows antibiotic, antifungal, insecticidal, and cancer cell antiproliferative and antihaptotactic (cell motility inhibitory) activity in vitro. The bbBeas gene encoding the BbBEAS nonribosomal peptide synthetase was isolated from B. bassiana and confirmed to be responsible for beauvericin biosynthesis by targeted disruption. BbBEAS utilizes D-2-hydroxyisovalerate (D-Hiv) and L-phenylalanine (Phe) for the iterative synthesis of a predicted N-methyl-dipeptidol intermediate, and forms the cyclic trimeric ester beauvericin from this intermediate in an unusual recursive process. Heterologous expression of the bbBeas gene in Escherichia coli to produce the 3189 amino acid, 351.9 kDa BbBEAS enzyme provided a strain proficient in beauvericin biosynthesis. Comparative infection assays with a BbBEAS knockout B. bassiana strain against three insect hosts revealed that beauvericin plays a highly significant but not indispensable role in virulence. © 2008 Elsevier Ltd. All rights reserved.

Yuquan, X. u., Wijeratne, E. K., Espinosa-Artiles, P., Gunatilaka, A. L., & Molnár, I. (2009). Combinatorial mutasynthesis of scrambled beauvericins, cyclooligomer depsipeptide cell migration inhibitors from Beauveria bassiana. ChemBioChem, 10(2), 345-354.
BIO5 Collaborators
Leslie Gunatilaka, Istvan Molnar

PMID: 19105175;Abstract:

Fungal cyclooligomer depsipeptides such as beauvericin, bassianolide, and enniatins display antibiotic, antifungal, insecticidal, broad-spectrum cancer cell antiproliferative, and cell migration inhibitory activities. We have identified a gene encoding a novel enzyme, ketoisovalerate reductase (KIVR), which is the sole provider of D-hydroxyisovalerate (D-Hiv), a common precursor for cyclooligomer depsipeptide biosynthesis in Beauveria bassiana. KIVR and related hypothetical oxidoreductases encoded in fungal genomes are similar to ketopantoate reductases but not to D-hydroxycarboxylate dehydrogenases. We demonstrate that a KIVR knockout B. bassiana strain can be used for the efficient mutasynthesis of unnatural beauvericin congeners. Simultaneous feeding of precursor analogues enabled the combinatorial mutasynthesis of scrambled beauvericins, some assembled entirely from unnatural precursors. The effects of the introduced structural changes on the antiproliferative and cell migration inhibitory ACHTUNGTRENNUNGactivities of these analogues were evaluated. © 2009 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Yuquan, X. u., Zhan, J., M., E., Burns, A. M., A., A., & Molnár, I. (2007). Cytotoxic and antihaptotactic beauvericin analogues from precursor-directed biosynthesis with the insect pathogen Beauveria bassiana ATCC 7159. Journal of Natural Products, 70(9), 1467-1471.
BIO5 Collaborators
Leslie Gunatilaka, Istvan Molnar

PMID: 17803266;Abstract:

Precursor-directed biosynthesis was used to produce analogues of the cyclic depsipeptide mycotoxin beauvericin (1) using the filamentous fungus Beauveria bassiana ATCC 7159. Feeding 30 analogues of D-2-hydroxyisovalerate and L-phenylalanine, the natural 2-hydroxycarboxylic acid and amino acid precursors of beauvericin, led to the biosynthesis of novel beauvericins. Six of these were isolated and characterized, and their cytotoxicity and directional cell migration (haptotaxis) inhibitory activity against the metastatic prostate cancer cell line PC-3M were evaluated. Replacement of one, two, or all three of the D-2-hydroxyisovalerate constituents in beauvericin (1) with 2-hydroxybutyrate moieties (beauvericins G1-3, compounds 2-4) caused a parallel decline of cell migration inhibitory activity and cytotoxicity, suggesting a requirement for a branched side chain for both of these biological activities at the corresponding positions of beauvericins. Replacement of one, two, or all three N-methyl-L-phenylalanine residues of beauvericin with N-methyl-L-3-fluorophenylalanine moieties (beauvericins H1-3, compounds 5-7) increased cytotoxicity without affecting antihaptotactic activity. © 2007 American Chemical Society and American Society of Pharmacognosy.

Molnar, I., Gunatilaka, L., & 7 co-authors, C. (2016). Diversity-Oriented Combinatorial Biosynthesis of Hybrid Polyketide Scaffolds from Azaphilone and Benzenediol Lactone Biosynthons. Organic Letters, 18, 1262-1265.
BIO5 Collaborators
Leslie Gunatilaka, Istvan Molnar